Moleculin Biotech, Inc. (MBRX)

Moleculin Biotech Statistics

Total Valuation

MBRX has a market cap or net worth of $18.64 million. The enterprise value is $12.33 million.

Market Cap	18.64M
Enterprise Value	12.33M

Important Dates

The last earnings date was Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

MBRX has 50.91 million shares outstanding. The number of shares has increased by 528.05% in one year.

Current Share Class	50.91M
Shares Outstanding	50.91M
Shares Change (YoY)	+528.05%
Shares Change (QoQ)	+135.60%
Owned by Insiders (%)	2.25%
Owned by Institutions (%)	4.65%
Float	49.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.39

Current Ratio	1.39
Quick Ratio	1.18
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-69.18%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-165.04%
Revenue Per Employee	n/a
Profits Per Employee	-$3.02M
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -86.59% in the last 52 weeks. The beta is 1.55, so MBRX's price volatility has been higher than the market average.

Beta (5Y)	1.55
52-Week Price Change	-86.59%
50-Day Moving Average	0.47
200-Day Moving Average	0.72
Relative Strength Index (RSI)	33.55
Average Volume (20 Days)	5,142,952

Short Selling Information

The latest short interest is 8.71 million, so 17.12% of the outstanding shares have been sold short.

Short Interest	8.71M
Short Previous Month	3.92M
Short % of Shares Out	17.12%
Short % of Float	17.51%
Short Ratio (days to cover)	2.16

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-24.21M
Pretax Income	-51.41M
Net Income	-51.41M
EBITDA	-24.10M
EBIT	-24.21M
Earnings Per Share (EPS)	-$3.05

Balance Sheet

The company has $6.70 million in cash and $390,000 in debt, giving a net cash position of $6.31 million or $0.12 per share.

Cash & Cash Equivalents	6.70M
Total Debt	390,000
Net Cash	6.31M
Net Cash Per Share	$0.12
Equity (Book Value)	-26.92M
Book Value Per Share	-0.54
Working Capital	2.20M

Cash Flow

Operating Cash Flow	-22.45M
Capital Expenditures	n/a
Free Cash Flow	-22.45M
FCF Per Share	-$0.44

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MBRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-528.05%
Shareholder Yield	-528.05%
Earnings Yield	-275.83%
FCF Yield	-120.46%

Analyst Forecast

The average price target for MBRX is $5.00, which is 1,265.75% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.00
Price Target Difference	1,265.75%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 22, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date	Mar 22, 2024
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	1